<?xml version="1.0" encoding="UTF-8"?>
<p>Currently there are no vaccines available for GAS; however, vaccination with the surface-localized M protein elicits protective opsonic antibodies [
 <xref rid="pone.0235139.ref017" ref-type="bibr">17</xref>â€“
 <xref rid="pone.0235139.ref020" ref-type="bibr">20</xref>] and experimental M protein-based vaccines have been used in animal studies [
 <xref rid="pone.0235139.ref021" ref-type="bibr">21</xref>] and human clinical trials [
 <xref rid="pone.0235139.ref022" ref-type="bibr">22</xref>, 
 <xref rid="pone.0235139.ref023" ref-type="bibr">23</xref>]. In addition, we previously showed that active vaccination targeting the M protein confers 100% protection against mortality by using a murine model of IAV-GAS superinfection [
 <xref rid="pone.0235139.ref024" ref-type="bibr">24</xref>].
</p>
